R&D

News

Novo Nordisk will open AI hub in London

Novo Nordisk is planning to open an artificial intelligence (AI) research facility in London, UK, as part of a drive to place the technology at the heart of its drug disco

R&D

Reinventing drug invention

So…where are all the new drugs?

Digital

Responsible integration of AI in pharmaceutical labs

As applications of generative AI (GenAI), and AI in general, extend to every industry, the dialogue surrounding its responsible integration remains front and centre.

R&D

Can China’s biotech industry weather frosty US relations?

The Chinese biotech industry has grown rapidly to become a major hub of research.

News

Sanofi says new drugs can add €10bn to sales by 2030

Sanofi said this morning that its pipeline includes 12 potential blockbuster drugs that could generate more than €10 billion ($11 billion) in annual sales by the end of th

News

MSD, Amgen back patient data specialist Culmination Bio

The venture capital arms of MSD and Amgen have provided $10 million in funding to Culmination Bio, a Utah start-up that aims to build the largest disease-agnostic patient

Novo Nordisk will open AI hub in London

Reinventing drug invention

Responsible integration of AI in pharmaceutical labs

Can China’s biotech industry weather frosty US relations?

Sanofi says new drugs can add €10bn to sales by 2030

MSD, Amgen back patient data specialist Culmination Bio

CDC panel votes to scrap hepatitis B birth dose advice

How to meet your physicians where they are online

R&D

Editor's Picks